Concepedia

Brenda Gaydos

BG

Statistics

Publications

16

Citations

1.5K

H-Index

15

Active since

2004

Affiliations

Eli Lilly (United States)(Current)

Pfizer (United States)

Novartis (United States)

Merck & Co., Inc., Rahway, NJ, USA (United States)

Berry & Associates (United States)

Brenda Gaydos is an author at Eli Lilly (United States) specializing in pharmacology, clinical trials, and adaptive dose-finding.

Publications per year

2004–2014

16

Publications

16

Practice effects and the use of alternate forms in serial neuropsychological testing

Leigh J. Beglinger, Brenda Gaydos, Kevin Duff et al. · Archives of Clinical Neuropsychology · 2005 · 361 citations · Full text

, , +17

Adaptive Designs in Clinical Drug Development—An Executive Summary of the PhRMA Working Group

Paul Gallo, Christy Chuang‐Stein, Vladimir Dragalin et al. · Journal of Biopharmaceutical Statistics · 2006 · 317 citations

, , +16

Innovative Approaches for Designing and Analyzing Adaptive Dose-Ranging Trials

Björn Bornkamp, Frank Bretz, Alex Dmitrienko et al. · Journal of Biopharmaceutical Statistics · 2007 · 193 citations

, , +15

Good Practices for Adaptive Clinical Trials in Pharmaceutical Product Development

Brenda Gaydos, Keaven M. Anderson, Donald A. Berry et al. · Drug Information Journal · 2009 · 125 citations

, , +15

Dose‐finding results in an adaptive, seamless, randomized trial of once‐weekly dulaglutide combined with metformin in type 2 diabetes patients (<scp>AWARD</scp>‐5)

Zachary Skrivanek, Brenda Gaydos, Jenny Y. Chien et al. · Diabetes Obesity and Metabolism · 2014 · 72 citations · Full text

, , +17

1–5 of 16